Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test
XTalks
AUGUST 18, 2020
SalivaDirect, a saliva-based COVID-19 test that was tested among players of the National Basketball Association (NBA), has been given emergency use authorization (EUA) by the US Food and Drug Administration (FDA). The EUA comes after Yale partnered with the NBA to study the efficacy of the saliva-based test.
Let's personalize your content